A detailed history of Two Sigma Investments, LP transactions in Personalis, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 78,259 shares of PSNL stock, worth $271,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,259
Holding current value
$271,558
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $93,128 - $496,162
78,259 New
78,259 $421,000
Q3 2023

Nov 14, 2023

SELL
$1.19 - $2.36 $31,892 - $63,248
-26,800 Reduced 55.37%
21,600 $26,000
Q2 2023

Aug 14, 2023

SELL
$1.8 - $3.19 $18,360 - $32,538
-10,200 Reduced 17.41%
48,400 $90,000
Q1 2023

May 15, 2023

BUY
$2.01 - $4.17 $15,346 - $31,837
7,635 Added 14.98%
58,600 $161,000
Q4 2022

Feb 14, 2023

SELL
$1.78 - $3.64 $96,200 - $196,723
-54,045 Reduced 51.47%
50,965 $100,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $827,505 - $1.52 Million
-286,334 Reduced 73.17%
105,010 $312,000
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $441,744 - $1.18 Million
135,090 Added 52.72%
391,344 $1.35 Million
Q1 2022

May 16, 2022

SELL
$7.56 - $14.3 $1 Million - $1.89 Million
-132,503 Reduced 34.08%
256,254 $2.1 Million
Q4 2021

Feb 14, 2022

SELL
$12.24 - $21.25 $385,535 - $669,332
-31,498 Reduced 7.49%
388,757 $5.55 Million
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $256,625 - $400,544
-15,376 Reduced 3.53%
420,255 $8.09 Million
Q2 2021

Aug 16, 2021

SELL
$18.15 - $27.75 $5.74 Million - $8.77 Million
-316,178 Reduced 42.06%
435,631 $11 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $9.24 Million - $22.8 Million
446,089 Added 145.91%
751,809 $18.5 Million
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $2.35 Million - $4.73 Million
107,503 Added 54.24%
305,720 $11.2 Million
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $2.7 Million - $4.78 Million
198,217 New
198,217 $4.3 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.